Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium ionophore A23187 is a polyether carboxylic acid antibiotic produced by fermentation of Streptomyces chartreusensis. It acts as a mobile ion-carrier (ionophore) that forms stable complexes with divalent cations—most selectively with Mn2+, followed by Ca2+ and Mg2+. By facilitating the transport of calcium ions across cell membranes, it increases intracellular calcium concentrations. This property makes it widely used in research to manipulate intracellular calcium levels and study cellular processes regulated by calcium signaling such as signal transduction, secretion, apoptosis, autophagy induction, and oocyte activation after ICSI in reproductive medicine. It also has antibiotic activity against Gram-positive bacteria and fungi[1][2][3][5][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium ionophore A23187.